ReviewJournal of family medicine and primary care2026
A scoping review on heavy menstrual bleeding and anemia: A less explored phenomenon.
Review in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2023, the World Health Organization (WHO) recognized heavy menstrual bleeding as one of the risk factors of anemia in "Accelerating anemia reduction: A complex framework for action." Heavy menstrual bleeding (HMB) leads to chronic increased blood loss causing iron deficiency anemia. Current National health programs in India do not address HMB as a risk factor of anemia in women. Owing to the high burden of anemia and emerging recognition of HMB as one of the causes for anemia, there is need to map the existing evidence on the burden, consequences and management of HMB in context of anemia. This scoping review aims to summarize available literature and identifying areas for future research. A literature search was conducted in the databases PubMed, Google Scholar, and Scopus to identify studies published from 2000 to 2024. The search included MeSH and keywords related to "heavy menstrual bleeding," "menorrhagia," "anemia," "iron deficiency anemia," and "management of HMB." Heavy menstrual bleeding is a prevalent health problem of menstruating women, affecting 4-63% of women globally. HMB is significantly associated with iron deficiency anemia. HMB affects the daily life of women with reported work loss of $1692 per women per year. Iron supplementation in therapeutic doses and hormonal contraceptives are the available medical treatment for HMB and associated anemia. The treatment of HMB with hormonal contraceptives have shown significant improvement in blood loss due to HMB and associated anemia. Heavy menstrual bleeding is a significant cause of iron deficiency anemia among women. Anemia Mukt Bharat program needs to address HMB as important cause for anemia and device strategy for the same. Anemia Mukt Bharat include the intervention for HMB prevention, screening, management, and referral.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.